1.Autoimmune diseases and fungal infections: immunological mechanisms and therapeutic approaches.
Chinese Medical Journal 2009;122(5):483-485
Candidiasis
;
drug therapy
;
immunology
;
metabolism
;
Diabetes Mellitus, Type 1
;
complications
;
drug therapy
;
immunology
;
therapy
;
Humans
;
Lupus Erythematosus, Systemic
;
drug therapy
;
immunology
;
metabolism
;
Mycoses
;
complications
;
immunology
;
therapy
;
Paraneoplastic Syndromes
;
drug therapy
;
immunology
;
metabolism
;
Pemphigus
;
drug therapy
;
immunology
;
metabolism
3.Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus.
Jia Xi PAN ; Sai Nan ZHU ; Shuang Ling LI ; Dong Xin WANG
Journal of Peking University(Health Sciences) 2022;54(5):981-990
OBJECTIVE:
Critically ill patients with solid tumors complicated with paraneoplastic pemphigus are usually treated in intensive care units (ICU) for perioperative management after surgical treatment. In this study, the clinical characteristics and predictors of long-term prognosis of these critically ill patients were analyzed.
METHODS:
the clinical and laboratory data of 63 patients with solid tumors complicated with paraneoplastic pemphigus admitted to ICU from 2005 to 2020 were retrospectively analyzed, and the survival status of the patients were followed up.
RESULTS:
Among the 63 patients, 79.4% had Castleman disease as the primary tumor, and 20.6% with other pathological types; 69.8% had severe-extensive skin lesions, and 30.2% had other skin lesions; the patients with bronchiolitis obliterans accounted for 44.4%, and 55.6% were not merged. Postoperative fungal infection occurred in 23.8% of the patients, and 76.2% without fungal infection. The median follow-up time was 95 months, and 25 patients died during the study period. The 1-year, 3-year and 5-year survival rates were 74.6% (95%CI 63.8%-85.4%), 67.4% (95%CI 55.6%-79.2%) and 55.1% (95%CI 47.9%-62.3%), respectively. The log-rank univariate analysis showed that the patients had age>40 years (P=0.042), preoperative weight loss>5 kg (P=0.002), preoperative albumin < 30 g/L (P < 0.001), paraneoplastic pemphigus complicated with bronchiolitis obliterans (P=0.002), and perioperative fungal infection (P < 0.001) had increased mortality. Cox univariate analysis showed that preoperative weight loss >5 kg (P=0.005), preoperative albumin < 30 g/L (P < 0.001), paraneoplastic pemphigus complicated with bronchiolitis obliterans (P=0.009), preoperative bacterial pulmonary infection (P=0.007), prolonged surgical time (P=0.048), postoperative oxygenation index (P=0.012) and low albumin (P=0.010) and hemoglobin concentration (P=0.035) in ICU, acute physiology and chronic health evaluation (APACHE Ⅱ) score (P=0.001); sequential organ failure assessment (SOFA) score (P=0.010), and postoperative fungal infection (P < 0.001) were risk factors for long-term survival. Cox regression model for multivariate analysis showed that preoperative weight loss > 5 kg (HR 4.44; 95%CI 1.47-13.38; P=0.008), and preoperative albumin < 30 g/L (HR 4.38; 95%CI 1.72-11.12; P=0.002), bronchiolitis obliterans (HR 2.69; 95%CI 1.12-6.50; P=0.027), and postoperative fungal infection (HR 4.85; 95%CI 2.01-11.72; P < 0.001) were independent risk factors for postoperative mortality.
CONCLUSION
The 5-year survival rate of critically ill patients undergoing surgery for paraneoplastic pemphigus combined with solid tumors is approximately 55.1%, with preoperative weight loss > 5 kg, albumin < 30 g/L, bronchiolitis obliterans and postoperative fungal infection were associated with an increased risk of near- and long-term postoperative mortality.
Adult
;
Albumins/therapeutic use*
;
Bronchiolitis Obliterans/pathology*
;
Critical Illness
;
Hemoglobins
;
Humans
;
Neoplasms/complications*
;
Paraneoplastic Syndromes/pathology*
;
Pemphigus/drug therapy*
;
Retrospective Studies
;
Weight Loss
4.A Case of Paraneoplastic Nephrotic Syndrome in a Patient with Ovarian Carcinoma.
Yong Tai KIM ; Sun Young RHA ; Chi Young SHIM ; Joo Hyuk SOHN ; Chul KIM ; Nae Choon YU ; Hyun Cheol CHUNG ; Joo Hang KIM ; Dae Suk HAN ; Byung Soo KIM ; Jae Kyung ROH
Yonsei Medical Journal 2003;44(3):539-543
Nephrotic syndrome is a rare manifestation of malignancy associated with paraneoplastic syndrome. Paraneoplastic nephrotic syndrome has been reported in various malignancies: malignant lymphoma, colon cancer, lung cancer and prostate cancer. However, an ovarian carcinoma associated with nephrotic syndrome has rarely been reported. Only six cases of ovarian carcinoma associated paraneoplastic nephrotic syndrome has been reported worldwide, but no cases have been reported in Korea. Here, we report a case of paraneoplastic nephrotic syndrome in a patient with an ovarian carcinoma. The patient presented with ascites, proteinuria and hypoalbuminemia. An initial computed tomography (CT) scan and ultrasonography evaluations showed no specific findings suggestive of an ovarian tumor. Despite treatment for nephrotic syndrome, the symptoms became more aggravated. There after, follow up evaluation at Yonsei University Medical Center, including serum CA 125, pelvis MRI and peritoneal fluid examination were performed. On the pelvis MRI, a left ovarian mass was detected with an ascitic fluid collection. The serum CA 125 level was elevated to 2211 U/ml. The peritoneal fluid cytological examination showed malignant cells suggestive of an ovarian carcinoma. Combination chemotherapies including paclitaxel plus carboplatin, topotecan plus gemcitabine and oxaliplatin plus capecitabine were administered to the patient, and complete remission was achieved on image and tumor marker studies. There was complete recovery from the nephrotic syndrome with no evidence of ascites and proteinuria. These findings suggest that nephrotic syndrome caused by paraneoplastic syndrome can be resolved only after the complete control of the underlying malignancy.
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Carcinoma/*complications/diagnosis/drug therapy
;
Female
;
Human
;
Magnetic Resonance Imaging
;
Middle Aged
;
Nephrotic Syndrome/*complications/drug therapy
;
Ovarian Neoplasms/*complications/diagnosis/drug therapy
;
Paraneoplastic Syndromes/*complications/drug therapy
;
Remission Induction
;
Support, Non-U.S. Gov't
;
Tomography, Emission-Computed
;
Tomography, X-Ray Computed
5.Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma.
Suh Yoon YANG ; Bong Ki CHA ; Gihyeon KIM ; Hyun Woong LEE ; Jae Gyu KIM ; Sae Kyung CHANG ; Hyung Joon KIM
The Korean Journal of Internal Medicine 2014;29(2):231-235
Dermatomyositis is an idiopathic inflammatory myopathy with typical cutaneous manifestations. It has been proposed that dermatomyositis may be caused by autoimmune responses to viral infections. Previous studies have shown an association between dermatomyositis and malignant tumors such as ovarian cancer, lung cancer, and colorectal cancer. However, a chronic hepatitis B virus (HBV) infection associated with dermatomyositis and hepatocellular carcinoma (HCC) has been very rarely reported. Here, we report a rare case of dermatomyositis coinciding with HBV-associated HCC. A 55-year-old male was confirmed to have HCC and dermatomyositis based on proximal muscle weakness, typical skin manifestations, elevated muscle enzyme levels, and muscle biopsy findings. This case suggests that HCC and/or a chronic HBV infection may be factors in the pathogenesis of dermatomyositis through a paraneoplastic mechanism.
Antiviral Agents/therapeutic use
;
Biopsy
;
Carcinoma, Hepatocellular/diagnosis/*virology
;
Dermatomyositis/diagnosis/drug therapy/*virology
;
Disease Progression
;
Fatal Outcome
;
Glucocorticoids/therapeutic use
;
Hepatitis B, Chronic/*complications/diagnosis/drug therapy
;
Humans
;
Liver Neoplasms/diagnosis/*virology
;
Male
;
Middle Aged
;
Paraneoplastic Syndromes/diagnosis/drug therapy/*virology
;
Risk Factors
;
Time Factors
;
Tomography, X-Ray Computed
;
Treatment Outcome